Abstract
Tumor angiogenesis has been defined as the growth of new capillary blood vessels in response to a tumor stimulus. This process is caused by a diffusable tumor product(s) and is directly responsible for enabling tumors to enlarge in size. Over the last ten years, significant progress has been made toward understanding the mechanism of this response. In addition, there now appears to be a potential for exploiting this understanding in order to assist with the diagnosis and possibly the treatment of solid tumors. This chapter will present an overview of the current knowledge in this field and the potential direction for this area in the near future.
Gerald W. Chodak is an American Urological Association Scholar, an American Cancer Society Junior Faculty Clinical Scholar and a Gould Scholar.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Algire GH, Chalkley HW, Legallais FY, Park HD: Vascular reactions of normal and malignant tissues in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants. J Natl Cancer Inst 6:73, 1945.
Ausprunk DH, Folkman J: Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Micro vas Res 14:53, 1977.
Azizkhan RG, Azizkhan JC, Zetter BR, Folkman J: Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med 152:931, 1980.
Ben Ezra D: Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants. Am J Ophthalmol. 86:455, 1978.
Brem S, Brem H, Folkman J, Finkelstein, Patz A: Prolonged tumor dormancy by prevention of neovascularization in the vitreous. Can Res 36:2807, 1976.
Brem H, Folkman J: Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 141:427, 1975.
Brem SS, Gullino PM, Medina D: Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science 199:880, 1977.
Bremm SS, Jensen HM, Gullino PM: Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer 41:239, 1978.
Chodak GW, Haudenschild C, Gittes RF, Folkman J: Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder. Ann Surg 192:762, 1980.
Chodak GW, Scheiner CJ, Zetter BR: Urine from patiens with transitional-cell carcinoma stimulates migration of capillary endothelial cells. New Engl J Med 305:869, 1981.
Chodak GW, Summerhays L, Folkman J: Angiogenesis assay of benign and malignant mammalian urothelium. Surg Forum 31:587, 1980.
Eisenstein R, Kuettner KE, Neapolitan C, Soble LW, Sorgente N: The resistance of certain tissues to invasion. III. Cartilage extracts inhibit the growth of fibroblasts and endothelial cells in culture. Am J Pathol 81:337, 1975.
Eisenstein R, Sorgente N, Soble LW, Miller A, Kuettner KE: The resistance of certain tissues to invasion. Penetrability of explanted tissues by vascularized mesenchyme. Am J Pathol 73:765, 1973.
Falterman KW, Ausprunk DH, Klein MD: Role of tumor angiogenesis factor in maintenance of tumor-induced vessels. Surg Forum 27:157, 1976.
Folkman J, Cotran R: Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 16:207, 1976.
Folkman J, Hochberg M: Self-regulation of growth in three dimensions. J Exp Med 138:745, 1973.
Form DM, Sidky YA, Kubai L, Auerbach R: PGE2-induced angiogenesis. Prostaglandins and cancer: In: First International Conference. New York: Alan R. Liss Inc, p 685, 1982.
Gimbrone MA, Jr, Gullino P: Neovascularization induced by intraocular xenografts of normal, preneoplastic and neoplastic mouse mammary tissues. J Natl Cancer Inst 56:305, 1976.
Gimbrone MA, Jr, Leapman SB, Cotran RS et al: Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136:261, 1072.
Greenblatt M, Shubik P: Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. J Natl Cancer Inst 41:111, 1968.
Kelly PJ, Suddith RL, Hutchison HT et al: Endothelial growth factor present in tissue culture of CNS tumors. J Neurosurg 44:342, 1976.
Kessler DA, Langer RS, Pless NA, Folkman J: Mast cells and tumor angiogenesis. Int J Cancer 18:703, 1976.
Klagsbrun M, Knighton D, Folkman J: Tumor angiogenesis activity in cells grown in tissue culture. Cancer Res 36:110, 1976.
Knighton D, Ausprunk D, Tapper D, Folkman J: Avascular and vascular phases of tumour growth in the chick embryo. Br J Cancer 35:347, 1977.
Langer R, Brem H, Falterman K et al: Isolation of a cartilage factor that inhibits tumor neovascularization. Science 193:70, 1976.
Langer R, Conn H, Vacanti J et al: Control of tumor growth in animals by infusion of an angiogenesis inhibitor. Proc Natl Acad Sci USA 77:4331, 1980.
Lopez-Pousa S, Ferner L, Vich JM, Domenech-Mateu J: Angiogenic activity in CSF in human malignancies. Experientia 37:413, 1981.
Matsuno H: Tumor angiogenesis factor (TAF) in cultured cells derived from central nervous system tumors in humans. Neurol Med Chir (Tokyo) 21:765, 1981.
McAuslan BR: A new theory of neovascularisation based on identification of an angiogenic factor and its effect on cultured endothelial cells. In: Control Mechanisms in Animal Cells, Jimenez de Asua et al. L. (eds.) New York: Raven Press, p 285, 1980.
McAuslan BR, Reily W: Endothelial cell phagokinesis in response to specific metal ions. Exp Cell Res 130:147, 1980.
Phillips P, Kumar S: Tumour angiogenesis factor (TAF) and its neutralisation by a xenogeneic antiserum. Int J Cancer 23:82, 1979.
Sakamoto S, Goldhaber P, Glimcher MJ: Mouse bone collagenase: the effect of heparin on the amount of enzyme released in tissue culture and on the activity of the enzyme. Calif Tissue Res 12:247, 1973.
Sorgante N, Kuettner KE, Soble LW, Eisenstein R: The resistance of certain tissues to invasion. II. Evidence for extractable factors in cartilage which inhibit invasion by vascularized mesenchyme. Lab Invest 32:217, 1975.
Suddith RL, Kelly PJ, Hutchison HT et al: In vitro demonstration of endothelial proliferative factor produced by neural cell lines. Science 190:682, 1975.
Tapper D, Langer R, Bellows AR, Folkman J: Angiogenesis capacity as a diagnostic marker for human eye tumors. Surgery 86:36, 1979.
Taylor S, Folkman J: Protamine is an inhibitor of angiogenesis. Nature 297:27, 1982.
Zetter BR: Migration of capillary endothelial cells is stimulated by tumour derived factors. Nature 285:41, 1980.
Ziehe M, Gullino PM: Angiogenesis and neoplastic progression in vitro. J Natl Cancer Inst 69:483, 1982.
Ziehe M, Jones J, Gullino P: Role of prostaglandin El and copper in angiogenesis. J Natl Cancer Inst 69:475, 1982.
Algire GJ: J Natl Cancer Inst 4:13–20, 1943.
Greenblatt M, Shubik P: J Natl Cancer Inst 41:111–124, 1968.
Folkman J: In: Carcinoma of the Colon and Antecedent Epithelium, Burdette WJ (ed). Springfield: C.C. Thomas, pp 113–127, 1970.
Folkman J: In: Advances in Cancer Research, Klein G, Weinhouse S (eds). New York: Academic Press, 331–358, 1947.
Folkman J, Cotran RS: In: International Review of Experimental Pathology, Richter GW, (ed). New York: Academic Press, pp 207–248, 1976.
Folkman J: Ann Surg 175:409–416, 1972.
Gimbrone MA Jr, Leapman S, Cotran RS, Folkman J: JNCI. 52:413–427, 1974.
Klagsbrun M, Knighton D, Folkman J: Cancer Res 36:110–114, 1976.
Langer R, Folkman J: Nature 263:797–800, 1976.
Folkman J, Haudenschild CC, Zetter B: Proc Natl Acad Sci USA 76:5217–5221, 1979.
Auerbach R: Lymphokines 4:69–88, 1981.
Polverini PJ, Cotran RS, Gimbrone MJ Jr, Unanue ER: Nature 269:804–806, 1977.
Banda MJ, Knighton DR, Hunt TK, Werb Z: Proc Natl Acad Sci USA 79:7773–7777, 1982.
Knighton DR, Hunt TK, Scheuenstuht H. Halliday H: Science 221:1283–1285, 1983.
Eisenstein R, Sorgente N, Soble LW, Miller A, Kuettner KE: AM J Pathol 73:765–774, 1973.
Eisenstein R, Kuettner K, Neapolitan C, Soble LW, Sorgente N: Am J Pathol 81:337–347, 1975.
Brem H, Folkman J: J Exp Med 141:427–439, 1975.
Brem SS, Jensen HM, Gullino PM: Cancer 41:239–244, 1978.
Ziche M, Gullino PM: J Natl Cancer Inst 69:483–487, 1982.
Chodak GW, Scheiner CJ, Zetter BR: New Engl J Med 305:869–874, 1971.
Zetter BR: Nature 285:41–43, 1981.
Schor AM, Kumar S, Phillips PJ: Int J Cancer 25:773, 1980.
Fenselau A, Watt S, Mello RJ: J Biol Chem 256:9605, 1981.
Weiss JB, Brown RA, Kumar S, Phillips P: Br J Cancer 40:498, 1979.
Gross JL, Moscatelli D, Jaffe EA, Rifkin DB: J Cell Biol 95:974–981, 1982.
Knighton DR, Hunt TK, Thakral KK, Goodson WH III: Ann Surg 196:379–388, 1982.
Wissler JH, Renner H: Immunobiol 14:438, 1982.
D’Amore PA, Glaser BM, Brunson SK, Fenselau AH: Proc Natl Acad Sci USA 78:3068–3072, 1981.
Taylor S, Folkman J: Nature 297:307–312, 1982.
Folkman J, Langer R, Linhardt RJ, Haudenschild C, Taylor S: Science 221:719–725, 1983.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Chodak, G.W., Folkman, J. (1984). Tumor Angiogenesis: Importance in Tumor Detection and Growth. In: Ratliff, T.L., Catalona, W.J. (eds) Urologic Oncology. Cancer Treatment and Research, vol 19. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2843-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2843-8_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9795-6
Online ISBN: 978-1-4613-2843-8
eBook Packages: Springer Book Archive